\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ serial\\ radiographs\\ as\\ a\\ means\\ to\\ track\\ the\\ progression\\/regression\\ of\\ the\\ ossification\\.\\ \\ cold\\ compresses\\,\\ ice\\,\\ elevation\\,\\ and\\ immobilization\\ to\\ treat\\ symptoms\\.\ \(0\)\
\-\ initial\\ a\\-p\\ radiograph\\ of\\ the\\ left\\ hip\\ shows\\ pinning\\ of\\ the\\ left\\ femoral\\ fracture\\ and\\ indistinct\\ flocculent\\ calcifications\\ in\\ the\\ lateral\\ quadriceps\\ musculature\\.\\ a\\-p\\ radiograph\\ of\\ the\\ left\\ hip\\ three\\ weeks\\ later\\ shows\\ that\\ the\\ ossifications\\ in\\ the\\ lateral\\ quadriceps\\ musculature\\ is\\ better\\ defined\\.\ \(0\)\
\-\ myositis\\ ossificans\ \(28\)\
\-\ myositis\\ ossificans\ \(28\)\
\-\ extraskeletal\\ chondrosarcoma\\ or\\ osteosarcoma\ \(0\)\
\-\ pseudomalignant\\ osseous\\ tumor\\ of\\ soft\\ tissue\ \(0\)\
\-\ soft\\ tissue\\ sarcoma\\ such\\ as\\ mfh\\ \\(before\\ maturation\\ of\\ myositis\\ ossificans\\)\ \(0\)\
\-\ this\\ 37\\-year\\-old\\ woman\\ with\\ diagnosed\\ autosomal\\ dominant\\ polycystic\\ kidney\\ disease\\ for\\ 10\\ years\\,\\ has\\ progressed\\ to\\ end\\ stage\\ renal\\ disease\\ and\\ required\\ a\\ renal\\ transplant\\.\\ \\ while\\ recovering\\ from\\ surgery\\ and\\ on\\ immunosuppression\\,\\ she\\ sustained\\ a\\ left\\ hip\\ fracture\\.\\ the\\ fracture\\ was\\ reduced\\ and\\ pinned\\ and\\ a\\ fibular\\ graft\\ was\\ placed\\.\\ radiographs\\ after\\ surgery\\ and\\ 3\\ weeks\\ postoperatively\\ when\\ the\\ patient\\ had\\ complaints\\ of\\ left\\ \\"hip\\"\\ swelling\\ and\\ pain\\,\\ along\\ with\\ mild\\ erythema\\.\ \(0\)\
\-\ sixty\\-75\\ \\%\\ of\\ patients\\ with\\ myositis\\ ossificans\\ have\\ a\\ history\\ of\\ trauma\\ or\\ surgery\\.\\ the\\ sites\\ most\\ commonly\\ involved\\ after\\ trauma\\ are\\ the\\ elbow\\,\\ thigh\\ and\\ less\\ frequently\\ the\\ shoulder\\ and\\ calf\\ and\\ the\\ more\\ common\\ the\\ the\\ proximal\\ than\\ distal\\ extremities\\.\\ after\\ prosthetic\\ placement\\,\\ the\\ soft\\ tissues\\ of\\ the\\ hips\\ and\\ knees\\ are\\ most\\ commonly\\ involved\\.\\ participants\\ of\\ high\\-impact\\ sports\\ \\(wrestling\\,\\ football\\,\\ and\\ rugby\\)\\ are\\ at\\ the\\ greatest\\ risk\\ for\\ developing\\ myositis\\ ossificans\\ due\\ to\\ blunt\\ trauma\\ sustained\\ during\\ participation\\.\\ \\ the\\ initial\\ clinical\\ signs\\ following\\ \\ trauma\\ are\\ non\\-specific\\ and\\ may\\ include\\ localized\\ warmth\\,\\ erythema\\,\\ tenderness\\,\\ and\\ occasionally\\ decreased\\ range\\ of\\ motion\\.\\ \\ in\\ a\\ period\\ of\\ 1\\-4\\ weeks\\ after\\ surgery\\ or\\ trauma\\,\\ the\\ soft\\ tissue\\ swelling\\ becomes\\ a\\ more\\ discrete\\ mass\\.\\ \\ \\ \\ \\ \ \(0\)\
\-\ in\\ the\\ acute\\ stage\\ prior\\ to\\ development\\ of\\ a\\ defined\\ mass\\,\\ \\ an\\ inflammatory\\ or\\ infective\\ process\\ such\\ as\\ thrombophlebitis\\ or\\ cellulitis\\ may\\ be\\ considered\\ clinically\\.\\ \\ \\ \\ \\ \\ \ \(0\)\
\-\ in\\ 7\\-10\\ days\\ after\\ the\\ traumatic\\ episode\\,\\ periosteal\\ reaction\\ may\\ be\\ seen\\.\\ initially\\ a\\ soft\\ tissue\\ mass\\ mass\\ have\\ more\\ flocculent\\ amorphous\\ calcifications\\ and\\ may\\ resemble\\ a\\ soft\\ tissue\\ malignancy\\.\\ within\\ 6\\ to\\ 8\\ weeks\\,\\ the\\ mass\\ develops\\ a\\ zonal\\ pattern\\ with\\ mature\\ ossification\\ peripherally\\ characteristic\\ of\\ myositis\\ ossificans\\.\\ \\ radiography\\ and\\ ct\\ show\\ this\\ zonal\\ pattern\\.\\ \\ \ \(0\)\
\-\ in\\ the\\ acute\\ stages\\,\\ treatment\\ includes\\ cold\\ compresses\\ along\\ with\\ rest\\,\\ elevation\\,\\ and\\ immobilization\\ followed\\ by\\ graduated\\ range\\ of\\ motion\\ exercises\\.\\ \\ if\\ pain\\ and\\ decreased\\ range\\ of\\ motion\\ persist\\ beyond\\ 6\\ months\\ to\\ a\\ year\\,\\ patients\\ can\\ be\\ treated\\ surgically\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ossificans\\:\\ 0\\.07565386745297158\ \(0\)\
\-\ myositis\\:\\ 0\\.07155490364278867\ \(0\)\
\-\ flocculent\\:\\ 0\\.03399518121276823\ \(0\)\
\-\ zonal\\:\\ 0\\.03399518121276823\ \(0\)\
\-\ hip\\:\\ 0\\.029990064952523866\ \(0\)\
\-\ soft\\:\\ 0\\.027501234766434582\ \(0\)\
\-\ a\\-p\\:\\ 0\\.025863786100440787\ \(0\)\
\-\ trauma\\:\\ 0\\.02573798217795076\ \(0\)\
\-\ compresses\\:\\ 0\\.025217955817657192\ \(0\)\
\-\ quadriceps\\:\\ 0\\.0243157777883796\ \(0\)\
\-\ musculature\\:\\ 0\\.023172556662894646\ \(0\)\
\-\ range\\:\\ 0\\.022732863543715856\ \(0\)\
\-\ motion\\:\\ 0\\.02270234187506193\ \(0\)\
\-\ cold\\:\\ 0\\.022695844836285693\ \(0\)\
\-\ tissue\\:\\ 0\\.022306400753883193\ \(0\)\
\-\ weeks\\:\\ 0\\.02136808596388677\ \(0\)\
\-\ sustained\\:\\ 0\\.021344610178036905\ \(0\)\
\-\ immobilization\\:\\ 0\\.020246743254583224\ \(0\)\
\-\ after\\:\\ 0\\.01947137888336126\ \(0\)\
\-\ progression\\/regression\\:\\ 0\\.019417441462481276\ \(0\)\
\-\ pseudomalignant\\:\\ 0\\.019417441462481276\ \(0\)\
\-\ sixty\\-75\\:\\ 0\\.019417441462481276\ \(0\)\
\-\ high\\-impact\\:\\ 0\\.019417441462481276\ \(0\)\
\-\ ossification\\:\\ 0\\.019110932200388953\ \(0\)\
\-\ elevation\\:\\ 0\\.018592064201902684\ \(0\)\
\-\ erythema\\:\\ 0\\.018503955537996646\ \(0\)\
\-\ surgery\\:\\ 0\\.018281930082469384\ \(0\)\
\-\ 37\\-year\\-old\\:\\ 0\\.017890685558164216\ \(0\)\
\-\ participants\\:\\ 0\\.017890685558164216\ \(0\)\
\-\ graduated\\:\\ 0\\.017890685558164216\ \(0\)\
\-\ may\\:\\ 0\\.016513906333904177\ \(0\)\
\-\ extraskeletal\\:\\ 0\\.016363929653847156\ \(0\)\
\-\ rugby\\:\\ 0\\.016363929653847156\ \(0\)\
\-\ 1\\-4\\:\\ 0\\.016363929653847156\ \(0\)\
\-\ infective\\:\\ 0\\.016363929653847156\ \(0\)\
\-\ stage\\:\\ 0\\.016057420391754833\ \(0\)\
\-\ ossifications\\:\\ 0\\.01587242403421233\ \(0\)\
\-\ mfh\\:\\ 0\\.01587242403421233\ \(0\)\
\-\ pinned\\:\\ 0\\.01587242403421233\ \(0\)\
\-\ defined\\:\\ 0\\.01586159764915204\ \(0\)\
\-\ involved\\:\\ 0\\.015790351573180227\ \(0\)\
\-\ participation\\:\\ 0\\.015470834702067057\ \(0\)\
\-\ maturation\\:\\ 0\\.015131295759716267\ \(0\)\
\-\ immunosuppression\\:\\ 0\\.015131295759716267\ \(0\)\
\-\ wrestling\\:\\ 0\\.015131295759716267\ \(0\)\
\-\ fracture\\:\\ 0\\.01488815636744127\ \(0\)\
\-\ 7\\-10\\:\\ 0\\.014577739750286959\ \(0\)\
\-\ resemble\\:\\ 0\\.014577739750286959\ \(0\)\
\-\ pattern\\:\\ 0\\.014389613828507834\ \(0\)\
\-\ prosthetic\\:\\ 0\\.01434566812989527\ \(0\)\
\-\ commonly\\:\\ 0\\.014204984332403707\ \(0\)\
\-\ postoperatively\\:\\ 0\\.014135733813145658\ \(0\)\
\-\ more\\:\\ 0\\.014122310413957046\ \(0\)\
\-\ calcifications\\:\\ 0\\.013996316099703757\ \(0\)\
\-\ recovering\\:\\ 0\\.013452573178115173\ \(0\)\
\-\ amorphous\\:\\ 0\\.013176883435925733\ \(0\)\
\-\ mass\\:\\ 0\\.013088777609554675\ \(0\)\
\-\ pinning\\:\\ 0\\.012711444903619109\ \(0\)\
\-\ thrombophlebitis\\:\\ 0\\.012608977908828596\ \(0\)\
\-\ swelling\\:\\ 0\\.012541017021943317\ \(0\)\
\-\ \\,\\:\\ 0\\.012521831224367917\ \(0\)\
\-\ initial\\:\\ 0\\.012473930146604882\ \(0\)\
\-\ along\\:\\ 0\\.012440765977350292\ \(0\)\
\-\ fibular\\:\\ 0\\.012417322893432935\ \(0\)\
\-\ track\\:\\ 0\\.012327406605943387\ \(0\)\
\-\ indistinct\\:\\ 0\\.012327406605943387\ \(0\)\
\-\ warmth\\:\\ 0\\.0121578888941898\ \(0\)\
\-\ persist\\:\\ 0\\.0121578888941898\ \(0\)\
\-\ radiograph\\:\\ 0\\.011990963233133757\ \(0\)\
\-\ means\\:\\ 0\\.011925817273798113\ \(0\)\
\-\ radiographs\\:\\ 0\\.011921897978864022\ \(0\)\
\-\ ice\\:\\ 0\\.011783661940895973\ \(0\)\
\-\ such\\:\\ 0\\.011767985858329747\ \(0\)\
\-\ exercises\\:\\ 0\\.011715882957048498\ \(0\)\
\-\ sports\\:\\ 0\\.011650127531608672\ \(0\)\
\-\ calf\\:\\ 0\\.011524227941652839\ \(0\)\
\-\ develops\\:\\ 0\\.011405137145903334\ \(0\)\
\-\ mature\\:\\ 0\\.011347922418142847\ \(0\)\
\-\ renal\\:\\ 0\\.011310464975586208\ \(0\)\
\-\ stages\\:\\ 0\\.01129215632126115\ \(0\)\
\-\ 6\\:\\ 0\\.011242820094162442\ \(0\)\
\-\ blunt\\:\\ 0\\.011237767306744913\ \(0\)\
\-\ peripherally\\:\\ 0\\.011237767306744913\ \(0\)\
\-\ decreased\\:\\ 0\\.011192759483368104\ \(0\)\
\-\ cellulitis\\:\\ 0\\.011184688999302049\ \(0\)\
\-\ polycystic\\:\\ 0\\.011132859709852281\ \(0\)\
\-\ graft\\:\\ 0\\.011132859709852281\ \(0\)\
\-\ hips\\:\\ 0\\.011082222004511536\ \(0\)\
\-\ football\\:\\ 0\\.011032722322018016\ \(0\)\
\-\ or\\:\\ 0\\.011029986222067264\ \(0\)\
\-\ knees\\:\\ 0\\.010936940137128722\ \(0\)\
\-\ beyond\\:\\ 0\\.010936940137128722\ \(0\)\
\-\ autosomal\\:\\ 0\\.010890566989115877\ \(0\)\
\-\ progressed\\:\\ 0\\.010890566989115877\ \(0\)\
\-\ non\\-specific\\:\\ 0\\.010890566989115877\ \(0\)\
\-\ discrete\\:\\ 0\\.01084515005695126\ \(0\)\
\-\ radiography\\:\\ 0\\.010714261465605883\ \(0\)\
\-\ treat\\:\\ 0\\.01063113298987274\ \(0\)\
\-\ left\\:\\ 0\\.010529793714459414\ \(0\)\
\-\ a\\:\\ 0\\.010482814144985055\ \(0\)\
\-\ transplant\\:\\ 0\\.010399061369481053\ \(0\)\
\-\ greatest\\:\\ 0\\.010399061369481053\ \(0\)\
\-\ shows\\:\\ 0\\.010349663875457616\ \(0\)\
\-\ thigh\\:\\ 0\\.010291594047521953\ \(0\)\
\-\ are\\:\\ 0\\.01026320592537094\ \(0\)\
\-\ sites\\:\\ 0\\.010256906036578913\ \(0\)\
\-\ reduced\\:\\ 0\\.00990755574984623\ \(0\)\
\-\ occasionally\\:\\ 0\\.00990755574984623\ \(0\)\
\-\ developing\\:\\ 0\\.009849588110380648\ \(0\)\
\-\ becomes\\:\\ 0\\.009849588110380648\ \(0\)\
\-\ osteosarcoma\\:\\ 0\\.009793106985681668\ \(0\)\
\-\ patients\\:\\ 0\\.009742619380467075\ \(0\)\
\-\ better\\:\\ 0\\.009711011402427853\ \(0\)\
\-\ elbow\\:\\ 0\\.009711011402427853\ \(0\)\
\-\ dominant\\:\\ 0\\.009606103805535221\ \(0\)\
\-\ end\\:\\ 0\\.009555466100194476\ \(0\)\
\-\ surgically\\:\\ 0\\.009530577211969954\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.009410184232811663\ \(0\)\
\-\ serial\\:\\ 0\\.00938687562195145\ \(0\)\
\-\ episode\\:\\ 0\\.0093183941526342\ \(0\)\
\-\ acute\\:\\ 0\\.0092946225951828\ \(0\)\
\-\ localized\\:\\ 0\\.009166427475350167\ \(0\)\
\-\ periosteal\\:\\ 0\\.008928071562045689\ \(0\)\
\-\ period\\:\\ 0\\.008800081185818197\ \(0\)\
\-\ be\\:\\ 0\\.008707643546325522\ \(0\)\
\-\ most\\:\\ 0\\.0086909037080532\ \(0\)\
\-\ rest\\:\\ 0\\.008679121367324552\ \(0\)\
\-\ reaction\\:\\ 0\\.008548556147215433\ \(0\)\
\-\ as\\:\\ 0\\.00854126105216384\ \(0\)\
\-\ sarcoma\\:\\ 0\\.008380799845529169\ \(0\)\
\-\ clinically\\:\\ 0\\.008252454232921293\ \(0\)\
\-\ development\\:\\ 0\\.008197727363787965\ \(0\)\
\-\ complaints\\:\\ 0\\.008170865528779554\ \(0\)\
\-\ frequently\\:\\ 0\\.008157556466101223\ \(0\)\
\-\ have\\:\\ 0\\.008151709596321992\ \(0\)\
\-\ lateral\\:\\ 0\\.008135101522575112\ \(0\)\
\-\ osseous\\:\\ 0\\.007991481537721902\ \(0\)\
\-\ before\\:\\ 0\\.00796700747290897\ \(0\)\
\-\ characteristic\\:\\ 0\\.00796700747290897\ \(0\)\
\-\ traumatic\\:\\ 0\\.007883428328494603\ \(0\)\
\-\ tissues\\:\\ 0\\.007725221864681263\ \(0\)\
\-\ initially\\:\\ 0\\.007660749656971763\ \(0\)\
\-\ placement\\:\\ 0\\.007639671571033105\ \(0\)\
\-\ placed\\:\\ 0\\.00761879328038433\ \(0\)\
\-\ the\\:\\ 0\\.007612846073988204\ \(0\)\
\-\ considered\\:\\ 0\\.007598111032917724\ \(0\)\
\-\ shoulder\\:\\ 0\\.007587842281583338\ \(0\)\
\-\ includes\\:\\ 0\\.007587842281583338\ \(0\)\
\-\ and\\:\\ 0\\.007533416539454076\ \(0\)\
\-\ extremities\\:\\ 0\\.007382569645244248\ \(0\)\
\-\ malignancy\\:\\ 0\\.007273325281501137\ \(0\)\
\-\ process\\:\\ 0\\.007246840274966332\ \(0\)\
\-\ femoral\\:\\ 0\\.00716078858291587\ \(0\)\
\-\ 8\\:\\ 0\\.007037703872795922\ \(0\)\
\-\ diagnosed\\:\\ 0\\.006921134706596929\ \(0\)\
\-\ risk\\:\\ 0\\.006817635787134553\ \(0\)\
\-\ later\\:\\ 0\\.006796076301746529\ \(0\)\
\-\ required\\:\\ 0\\.006774725796888247\ \(0\)\
\-\ kidney\\:\\ 0\\.006630800561784163\ \(0\)\
\-\ signs\\:\\ 0\\.006624176066048579\ \(0\)\
\-\ to\\:\\ 0\\.006584750570706836\ \(0\)\
\-\ inflammatory\\:\\ 0\\.006527127630378908\ \(0\)\
\-\ less\\:\\ 0\\.006374317190138068\ \(0\)\
\-\ three\\:\\ 0\\.006344987287107732\ \(0\)\
\-\ 10\\:\\ 0\\.006344987287107732\ \(0\)\
\-\ available\\:\\ 0\\.006327574997444488\ \(0\)\
\-\ followed\\:\\ 0\\.006310299276164695\ \(0\)\
\-\ disease\\:\\ 0\\.006153028815928213\ \(0\)\
\-\ while\\:\\ 0\\.005922134889542541\ \(0\)\
\-\ clinical\\:\\ 0\\.005791431277678424\ \(0\)\
\-\ show\\:\\ 0\\.005777876507690806\ \(0\)\
\-\ days\\:\\ 0\\.005768886114916251\ \(0\)\
\-\ during\\:\\ 0\\.0057599322685546435\ \(0\)\
\-\ tenderness\\:\\ 0\\.005724476482118135\ \(0\)\
\-\ proximal\\:\\ 0\\.005650976171160827\ \(0\)\
\-\ treated\\:\\ 0\\.00563403267859881\ \(0\)\
\-\ in\\:\\ 0\\.005569126389518788\ \(0\)\
\-\ years\\:\\ 0\\.005526967262155248\ \(0\)\
\-\ when\\:\\ 0\\.005390597439682832\ \(0\)\
\-\ following\\:\\ 0\\.005342021490971693\ \(0\)\
\-\ she\\:\\ 0\\.005283669915097296\ \(0\)\
\-\ include\\:\\ 0\\.005280073762181248\ \(0\)\
\-\ months\\:\\ 0\\.005140839856145523\ \(0\)\
\-\ distal\\:\\ 0\\.005117353720145434\ \(0\)\
\-\ if\\:\\ 0\\.005107364391587303\ \(0\)\
\-\ due\\:\\ 0\\.00502263690077718\ \(0\)\
\-\ mild\\:\\ 0\\.004956505405134664\ \(0\)\
\-\ than\\:\\ 0\\.004931825671626155\ \(0\)\
\-\ common\\:\\ 0\\.004925698704749774\ \(0\)\
\-\ prior\\:\\ 0\\.004832847515864237\ \(0\)\
\-\ symptoms\\:\\ 0\\.004690875499775637\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.00462584810051061\ \(0\)\
\-\ pain\\:\\ 0\\.004597392808505439\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.004536893176172342\ \(0\)\
\-\ 3\\:\\ 0\\.004407435080851409\ \(0\)\
\-\ \\%\\:\\ 0\\.004390574963317198\ \(0\)\
\-\ tumor\\:\\ 0\\.0043881768757947385\ \(0\)\
\-\ of\\:\\ 0\\.004362477122391637\ \(0\)\
\-\ was\\:\\ 0\\.004353645472306991\ \(0\)\
\-\ woman\\:\\ 0\\.004347803849094507\ \(0\)\
\-\ can\\:\\ 0\\.004269212230108083\ \(0\)\
\-\ this\\:\\ 0\\.004234084640150366\ \(0\)\
\-\ had\\:\\ 0\\.004061343214186583\ \(0\)\
\-\ treatment\\:\\ 0\\.003809728985905038\ \(0\)\
\-\ seen\\:\\ 0\\.0037194440860521816\ \(0\)\
\-\ within\\:\\ 0\\.003590597815828374\ \(0\)\
\-\ has\\:\\ 0\\.0035345814328067797\ \(0\)\
\-\ that\\:\\ 0\\.0032510588734775848\ \(0\)\
\-\ for\\:\\ 0\\.0032119301702322254\ \(0\)\
\-\ \\(\\:\\ 0\\.0031822102477703108\ \(0\)\
\-\ \\)\\:\\ 0\\.003143337850719406\ \(0\)\
\-\ by\\:\\ 0\\.0031340768793939977\ \(0\)\
\-\ from\\:\\ 0\\.0027895059761106\ \(0\)\
\-\ not\\:\\ 0\\.0027198649157311352\ \(0\)\
\-\ ct\\:\\ 0\\.0026328274303789494\ \(0\)\
\-\ an\\:\\ 0\\.002602786044680022\ \(0\)\
\-\ history\\:\\ 0\\.00259959149274688\ \(0\)\
\-\ at\\:\\ 0\\.0025501391031533768\ \(0\)\
\-\ year\\:\\ 0\\.0021059587428918828\ \(0\)\
\-\ patient\\:\\ 0\\.0018867663676572423\ \(0\)\
\-\ \\.\\:\\ 0\\.001642049026529233\ \(0\)\
\-\ on\\:\\ 0\\.0015944735955185643\ \(0\)\
\-\ with\\:\\ 0\\.0012885922476860105\ \(0\)\
\-\ is\\:\\ 0\\.001238525943578691\ \(0\)\
